Dobutamine and milrinone equally effective in PLCS in preterm infants: Study

Recent research shows that Inotropic drugs like Dobutamine and milrinone possess similar therapeutic effects in the treatment of post ligation cardiac syndrome in preterm infants. The study was published in the journal, American Journal of perinatology, 2020.

Patent ductus arteriosus is associated with many complications like neonatal morbidity, necrotizing enterocolitis, bronchopulmonary dysplasia, hemorrhagic pulmonary edema, retinopathy of prematurity, and death. Drugs like prostaglandin inhibitors are generally used for closure, but if they are unsuccessful then ligation is recommended. The post PDA ligation can often be complicated due to acute respiratory and hemodynamic instability. Inotropic drugs are generally used to maintain stability. Myocardial dysfunction secondary to vascular tone dysregulation often prompts the use of inotropic drugs.

Researchers from Erciyes University Medical Faculty, Kayseri, Turkey conducted a study to detect the therapeutic effect of dobutamine or milrinone which are the two main medicines suggested in the treatment of post ligation cardiac syndrome (PLCS).

The authors conducted a retrospective review of a cohort of infants with PLCS between March 2012 and December 2018. There were two groups dobutamine study group-DSG and milrinone study group-MSG. Both before and after ligation parameters like respiration, cardiac, echocardiography, and perfusion were assessed. Based on the data, both the effects of the medicines on PLCS and the difference between their therapeutic effects were studied.